Early mortality and AIDS progression despite high initial antiretroviral therapy adherence and virologic suppression in Botswana - Wikidata - wikimedia - TriplyDB

Early mortality and AIDS progression despite high initial antiretroviral therapy adherence and virologic suppression in Botswana

Early mortality and AIDS progression despite high initial antiretroviral therapy adherence and virologic suppression in Botswana

http://www.wikidata.org/entity/Q33941267

about

Marked sex differences in all-cause mortality on antiretroviral therapy in low- and middle-income countries: a systematic review and meta-analysis Alcohol use, antiretroviral therapy adherence, and preferences regarding an alcohol-focused adherence intervention in patients with human immunodeficiency virus.Changing predictors of mortality over time from cART start: implications for care.Sex differences in HIV outcomes in the highly active antiretroviral therapy era: a systematic review Immuno-virologic outcomes and immuno-virologic discordance among adults alive and on anti-retroviral therapy at 12 months in Nigeria Trends in and determinants of loss to follow up and early mortality in a rapid expansion of the antiretroviral treatment program in Vietnam: findings from 13 outpatient clinics Rates and risk factors associated with the progression of HIV to AIDS among HIV patients from Zhejiang, China between 2008 and 2012 Causes of death and risk factors for mortality among HIV-infected patients receiving antiretroviral therapy in Korea.The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa.Measuring Health Literacy Among Adults with HIV Infection in Mozambique: Development and Validation of the HIV Literacy Test Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults.Effects of sex and alcohol use on antiretroviral therapy outcomes in Botswana: a cohort study.

P2860

Q28068815-05773FE4-E8A1-4F5B-80B8-B3745C7C0F11 Q30575455-62F12CCB-3B93-4B59-9FCF-8D724654E22E Q33564975-8637B3E2-F0C6-437D-B12E-32597BD67688 Q33566578-7BAD53D5-6232-4FA9-9D36-911E857B26FE Q34604679-8619B795-2E2C-42E7-A01D-2D4322118C01 Q34996955-4D444048-C479-4B1D-927F-2B190C85721B Q36092212-6F6497B5-55CB-439F-8EFC-488FAA03382E Q37001718-500ADB61-DFEA-4586-B887-F3C77CC3EA8E Q37455928-BD116DDB-C6C0-4087-89FF-87C93C6B5F23 Q37639495-5F2CEDB1-4E05-4E90-AB38-4982D9B367D8 Q38662366-F41976D1-5B36-4FF6-924A-48BD44C22A32 Q40603410-A738A6DD-4D4C-4A62-86B1-03877E4834C1

P2860

Early mortality and AIDS progression despite high initial antiretroviral therapy adherence and virologic suppression in Botswana

http://www.wikidata.org/entity/Q33941267

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Early mortality and AIDS progr ...... ologic suppression in Botswana

@ast

Early mortality and AIDS progr ...... ologic suppression in Botswana

@en

type

label

Early mortality and AIDS progr ...... ologic suppression in Botswana

@ast

Early mortality and AIDS progr ...... ologic suppression in Botswana

@en

prefLabel

Early mortality and AIDS progr ...... ologic suppression in Botswana

@ast

Early mortality and AIDS progr ...... ologic suppression in Botswana

@en

P1433

Q33941267-5D0E3FE2-94DF-4EF3-A9E9-CFD0324F0EB0

P1476

Q33941267-74608B2E-B8B5-4917-81FD-65F071ED383B

P2093

Q33941267-49B2769E-3AB7-4A46-AC18-078293086786

Q33941267-50A84862-7D8D-45EC-8E4F-719AC1059F0B

Q33941267-6538E686-1185-476E-B8F2-B8C117F52CA1

Q33941267-6F789B8E-2867-4CE4-96E8-F03036ED2BCC

Q33941267-7D6E9D3C-3E93-462A-9ACD-971A67F7D09B

Q33941267-92E1CAD1-01B3-4CF5-B228-52436E4A0448

Q33941267-AB8B7A1B-7838-41CC-84FF-19F261A9DCDB

Q33941267-D4C753E5-CF7F-42DE-BEF7-997DAEF975B2

Q33941267-E937BAE4-A569-4AA1-A4D3-304BE27E655C

P2860

Q33941267-0219A8E2-CC8B-443A-B610-B8435B0DAA0C

Q33941267-0F54C6F3-E6A6-4A54-BB37-46854A57358B

Q33941267-128104B0-7B4C-4A6F-844F-5504C09329F0

Q33941267-1743CC1B-244E-4431-8E36-7ECAB9C9B06D

Q33941267-1A290E95-F866-4329-9001-9D4D3F2E592B

Q33941267-1FE0254C-893B-4BD5-B3AC-CAC6AE58EFD6

Q33941267-2287D747-B2EF-4C83-BE73-CF2E99E9E87D

Q33941267-278EAC97-18CE-4182-B8E2-8E1C4427740E

Q33941267-27F1F4F2-60EC-4D0D-AE92-915EFFC9196A

Q33941267-31276AEC-F0B5-4F76-8426-ECA75F8485B8

P304

Q33941267-69C1ADC9-9D19-4978-9B27-A9EE15782A68

P31

Q33941267-90743FCD-9E3C-4332-93E7-43AC59DABF74

P356

Q33941267-E864F0B3-1DA2-489A-A711-A23231BA074D

P407

Q33941267-5938D7CE-05F7-4D52-9A77-148657A164DF

P433

Q33941267-44AB5B7C-90EC-4E28-8EDE-B95CE13EE031

P478

Q33941267-E0A5CCC0-118F-4433-9526-ED5769FD848D

P50

Q33941267-DC50CF38-0A26-4FF5-BFB1-37BABDAD24CE

P577

Q33941267-D66682C6-33F9-402B-87FC-0D13C284AC10

P5875

Q33941267-56EAF132-7E10-4924-94C0-EBCCCDAF2241

P698

Q33941267-D00769BE-9B0D-45AD-8AF6-25F4AD049D9F

P921

Q33941267-123871A5-6F17-49DD-97BE-CF081A946D81

Q33941267-6050050F-3C42-4A5A-A0AA-9CDC86776B78

Q33941267-67EE93EA-3DF3-4487-B3C9-A8C44D95A4F9

P932

Q33941267-B5A82B85-015C-4B58-96DC-43FCE5E4E671

P356

JOURNAL.PONE.0020010

P1433

P1476

Early mortality and AIDS progr ...... ologic suppression in Botswana

@en

P2093

Andrew P Steenhoff

http://www.w3.org/2001/XMLSchema#string

Craig W Newcomb

http://www.w3.org/2001/XMLSchema#string

Gloria Lesetedi

http://www.w3.org/2001/XMLSchema#string

Jean B Nachega

http://www.w3.org/2001/XMLSchema#string

Katherine T Steele

http://www.w3.org/2001/XMLSchema#string

Robert Gross

http://www.w3.org/2001/XMLSchema#string

Rudo Nthobatsang

http://www.w3.org/2001/XMLSchema#string

Scarlett L Bellamy

http://www.w3.org/2001/XMLSchema#string

Tumelo Rantleru

http://www.w3.org/2001/XMLSchema#string

P2860

Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study

Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings

Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review

Overestimates of survival after HAART: implications for global scale-up efforts

Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis.

Effect of pulmonary tuberculosis on mortality in patients receiving HAART.

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies.

Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies.

HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis.

Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring.

P304

e20010

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0020010

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Gregory P Bisson

P577

2011-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51243260

http://www.w3.org/2001/XMLSchema#string

P698

21698283

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

3115945

http://www.w3.org/2001/XMLSchema#string